Stocktoria
Cullinan Therapeutics, Inc. CGEM
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-01-08
Cullinan Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 3,550,207 | $61.9M |
| Point72 Asset Management, L.P. | 905,376 | $12.9M |
| TWO SIGMA INVESTMENTS, LP | 522,047 | $7.4M |
| MILLENNIUM MANAGEMENT LLC | 366,582 | $5.2M |
| AQR CAPITAL MANAGEMENT LLC | 360,874 | $5.1M |
| RENAISSANCE TECHNOLOGIES LLC | 324,111 | $4.6M |
| CITADEL ADVISORS LLC | 292,378 | $4.2M |
Source: SEC EDGAR filings · CIK 0001789972 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.